Article
In-vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
2022-11-01
Abstract excerpt
Targeting metabolic vulnerabilities has been proposed as a therapeutic strategy in renal cell carcinoma (RCC). Here, we analyzed metabolism in patient-derived xenografts (tumorgrafts) from diverse forms of RCC. Tumorgrafts from VHL -mutant clear cell RCC (ccRCC) retained metabolic features of human ccRCC and engage in oxidative and reductive glutamine metabolism. We used several approaches to suppress glutamine m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 68985a0c-2d05-5672-b9e9-81cad075bc8a
- DOI
- 10.1101/2022.10.31.514397
